Retraction: The parenteral vitamin C improves sepsis and sepsis-induced multiple organ dysfunction syndrome via preventing cellular immunosuppression (Mediators of Inflammation (2017) 2017 (12) DOI: 10.1155/2017/4024672);The Parenteral Vitamin C Improves Sepsis and Sepsis-Induced Multiple Organ Dysfunction Syndrome via Preventing Cellular Immunosuppression

Mediators of Inflammation

Volumn 2017, Issue , 2017, Pages

  Gao, Yu Lei ^a   Lu, Bin ^a   Zhai, Jian Hua ^a   Liu, Yan Cun ^a   Qi, Hai Xia ^a   Yao, Ying ^a   Chai, Yan Fen ^a   Shou, Song Tao ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 10; INTERLEUKIN 4; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; FORKHEAD TRANSCRIPTION FACTOR; GULONOLACTONE OXIDASE; INTERLEUKIN 2 RECEPTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCORBIC ACID DEFICIENCY; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; IMMUNOREGULATION; METHYLATION; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; POLYCLONAL ACTIVATION; REGULATORY T LYMPHOCYTE; SEPSIS; SURVIVAL RATE; ANIMAL; C57BL MOUSE; CD4+ T LYMPHOCYTE; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; ASCORBIC ACID; CD4-POSITIVE T-LYMPHOCYTES; CTLA-4 ANTIGEN; FORKHEAD TRANSCRIPTION FACTORS; IMMUNOSUPPRESSION; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; L-GULONOLACTONE OXIDASE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MULTIPLE ORGAN FAILURE; SEPSIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 85012194070     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2020/8462563     Document Type: Erratum

References (28)

1. M. Singer, C. S. Deutschman, C. W. Seymour et al., "The third international consensus definitions for sepsis and septic shock (Sepsis-3), "The Journal of theAmericanMedical Association, vol. 315, no. 8, pp. 801-810, 2016.
2. K.-M. Kaukonen, M. Bailey, D. Pilcher, D. J. Cooper, and R. Bellomo, "Systemic inflammatory response syndrome criteria in defining severe sepsis, "The New England Journal ofMedicine, vol. 372, no. 17, pp. 1629-1638, 2015.
3. D. F. Gaieski, J. M. Edwards, M. J. Kallan, and B. G. Carr, "Benchmarking the incidence and mortality of severe sepsis in the united states, " Critical CareMedicine, vol. 41, no. 5, pp. 1167-1174, 2013.
4. B. D. Winters, M. Eberlein, J. Leung, D. M. Needham, P. J. Pronovost, and J. E. Sevransky, "Long-term mortality and quality of life in sepsis: a systematic review, " Critical Care Medicine, vol. 38, no. 5, pp. 1276-1283, 2010.
5. S. Inoue, K. Suzuki-Utsunomiya, Y. Okada et al., "Reduction of immunocompetent T cells followed by prolonged lymphopenia in severe sepsis in the elderly, " Critical Care Medicine, vol. 41, no. 3, pp. 810-819, 2013.
6. L. P. Skrupky, P. W. Kerby, and R. S. Hotchkiss, "Advances in the management of sepsis and the understanding of key immunologic defects, " Anesthesiology, vol. 115, no. 6, pp. 1349-1362, 2011.
7. J. S. Boomer, K. To, K. C. Chang et al., "Immunosuppression in patients who die of sepsis and multiple organ failure, " The Journal of the American Medical Association, vol. 306, no. 23, pp. 2594-2605, 2011.
8. C. J. Darcy, G. Minigo, K. A. Piera et al., "Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients, " Critical Care, vol. 18, no. 4, article R163, 2014.
9. K. Chang, C. Svabek, C. Vazquez-Guillamet et al., "Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis, " Critical Care, vol. 18, no. 1, article R3, 2014.
10. D. C. Nascimento, J. C. Alves-Filho, F. Sônego et al., "Role of regulatory T cells in long-term immune dysfunction associated with severe sepsis, " Critical Care Medicine, vol. 38, no. 8, pp. 1718-1725, 2010.
11. R. Tatura, M. Zeschnigk, W. Hansen et al., "Relevance of Foxp3+ regulatory T cells for early and late phases of murine sepsis, " Immunology, vol. 146, no. 1, pp. 144-156, 2015.
12. Q. Y. Liu, Y. M. Yao, Y. Yu et al., "Astragalus polysaccharides attenuate postburn sepsisvia inhibiting negative immunoregulation of CD4+CD25highT cells, " PLoS ONE, vol. 6, no. 6, Article ID e19811, 2011.
13. X.-M. Zhu, Y.-M. Yao, H.-P. Liang et al., "High mobility group box-1 protein regulate immunosuppression of regulatory T cells through toll-like receptor 4, " Cytokine, vol. 54, no. 3, pp. 296-304, 2011.
14. Y. Zhang, Y.-M. Yao, L.-F. Huang, N. Dong, Y. Yu, and Z.-Y. Sheng, "The potential effect and mechanism of high-mobility group box 1 protein on regulatory T cell-mediated immunosuppression, " Journal of Interferon and Cytokine Research, vol. 31, no. 2, pp. 249-257, 2011.
15. Y.-Y. Luan, C.-F. Yin, Q.-H. Qin et al., "Effect of regulatory T cells on promoting apoptosis of T lymphocyte and its regulatory mechanism in sepsis, " Journal of Interferon and Cytokine Research, vol. 35, no. 12, pp. 969-980, 2015.
16. B. J. Fisher, D. Kraskauskas, E. J. Martin et al., "Attenuation of sepsis-induced organ injury in mice by vitamin C, " Journal of Parenteral and EnteralNutrition, vol. 38, no. 7, pp. 825-839, 2014.
17. P. E. Marik, "'Vitamin S' (Steroids) and Vitamin C for the treatment of severe sepsis and septic shock!, " Critical CareMedicine, vol. 44, no. 6, pp. 1228-1229, 2016.
18. J.-M. Hong, J.-H. Kim, J. S. Kang, W. J. Lee, and Y.-I. Hwang, "Vitamin C is taken up by human T cells via sodium-dependent vitamin C transporter 2 (SVCT2) and exerts inhibitory effects on the activation of these cells in vitro, " Anatomy and Cell Biology, vol. 49, no. 2, pp. 88-98, 2016.
19. J. Manning, B. Mitchell, D. A. Appadurai et al., "Vitamin C promotes maturation of T-cells, " Antioxidants and Redox Signaling, vol. 19, no. 17, pp. 2054-2067, 2013.
20. S. Mburu, J. L. Marnewick, A. Abayomi, and H. Ipp, "Modulation of LPS-induced CD4+ T-cell activation and apoptosis by antioxidants in untreated asymptomatic HIV infected participants: An In Vitro Study, " Clinical and Developmental Immunology, vol. 2013, Article ID 631063, 9 pages, 2013.
21. P. H. Tan, P. Sagoo, C. Chan et al., "Inhibition of NF-kB and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells, " Journal of Immunology, vol. 174, no. 12, pp. 7633-7644, 2005.
22. V. S. Nair, M. H. Song, and K. I. Oh, "Vitamin C facilitates demethylation of the Foxp3 enhancer in a Tet-dependent manner, " Journal of Immunology, vol. 196, no. 5, pp. 2119-2131, 2016.
23. Y.-L. Gao, Y.-F. Chai, A.-L. Qi et al., "Neuropilin-1 CD4+CD25+ regulatory T cells exhibit primary negative immunoregulation in sepsis, " Mediators of Inflammation, vol. 2016, Article ID 7132158, 11 pages, 2016.
24. Y. L. Gao, Y. F. Chai, N. Dong et al., "Tuftsin-derived T-peptide prevents cellular immunosuppression and improves survival rate in septic mice, " Scientific Reports, vol. 5, Article ID 16725, 2015.
25. Z. Yang, Y. Zhang, L. Dong et al., "The reduction of peripheral blood CD4+ T cell indicates persistent organ failure in acute pancreatitis, " PLoSONE, vol. 10, no. 5, Article IDe0125529, 2015.
26. R. Sharma, P. R. Sharma, Y. C. Kim et al., "IL-2-controlled expression ofmultiple T cell trafficking genes andTh2 cytokines in the regulatory T cell-deficient scurfy mice: implication to multiorgan inflammation and control of skin and lung inflammation, " The Journal of Immunology, vol. 186, no. 2, pp. 1268-1278, 2011.
27. M. J. A. J. Huijskens, M. Walczak, N. Koller et al., "Technical advance: ascorbic acid induces development of double-positive T cells from human hematopoietic stem cells in the absence of Stromal cells, " Journal of Leukocyte Biology, vol. 96, no. 6, pp. 1165-1175, 2014.
28. H.-J. Kim, R. A. Barnitz, T. Kreslavsky et al., "Stable inhibitory activity of regulatory T cells requires the transcription factor Helios, " Science, vol. 350, no. 6258, pp. 334-339, 2015.